ABI
PRGO icon

Adamant Biomedical Investments’s Perrigo PRGO Stock Holding History

Adamant Biomedical Investments’s Portfolio PRGO Stock Details PRGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$3.33M Sell
20,000
-10,750
-35% -$1.68M 0.8% 45
2014
Q3 		$4.15M Buy
+30,750
New +$4.59M 1.04% 38

Other funds holding PRGO

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adamant Biomedical Investments's PRGO Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Perrigo (PRGO) stake by 35% in Q4 2014, selling an estimated $1.68M and leaving 20,000 shares worth $3.33M. The position accounts for 0.8% of the portfolio, ranked #45.

Adamant Biomedical Investments first reported a position in PRGO in Q3 2014 and has held it in 2 quarters since. The position peaked at $4.15M in Q3 2014. 526 funds tracked by Wall St. Rank hold PRGO as of Q4 2014.

  • Adamant Biomedical Investments held 20,000 shares of Perrigo worth $3.33M as of Q4 2014.
  • Adamant Biomedical Investments sold 10,750 Perrigo shares in Q4 2014, an estimated $1.68M.
  • Perrigo made up 0.8% of Adamant Biomedical Investments's portfolio in Q4 2014, its #45 holding.
  • Adamant Biomedical Investments first reported a position in Perrigo in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's Perrigo position peaked at $4.15M in Q3 2014.
  • 526 funds tracked by Wall St. Rank held Perrigo as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.